Niraparib for Advanced Ovarian Cancer with HRD+ Status Approved by FDA

Niraparib was approved by the (FDA) for previously treated advanced ovarian, fallopian, or primary peritoneal cancers.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news